Capsazepine decreases corneal pain syndrome in severe dry eye disease

Authors
D Fakih, A Guerrero-Moreno, C Baudouin


Lab
Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France

Journal
Journal of Neuroinflammation

Abstract
Dry eye disease (DED) is a multifactorial disease of the ocular surface accompanied by neurosensory abnormalities. Here, we evaluated the effectiveness of transient receptor potential vanilloid-1 (TRPV1) blockade to alleviate ocular pain, neuroinflammation, and anxiety-like behavior associated with severe DED.

BIOSEB Instruments Used:
Elevated Plus Maze : EPM3C - 3 clicks only ! (BIO-EPM3C)

Publication request

Thank you for your interest in our product range and your request for this publication, which will be sent to you if the research team and the journal allow it. Our commercial team will contact you as soon as possible.